Nevro Corporation

États‑Unis d’Amérique

Retour au propriétaire

1-100 de 271 pour Nevro Corporation Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 220
        Marque 51
Juridiction
        États-Unis 186
        International 49
        Europe 22
        Canada 14
Date
Nouveautés (dernières 4 semaines) 1
2026 septembre (MACJ) 1
2026 août 1
2026 juin 4
2026 mai 2
Voir plus
Classe IPC
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques 178
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque 112
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs 66
A61N 1/378 - Alimentation en courant électrique 35
A61N 1/06 - Électrodes pour traitement à haute fréquence 33
Voir plus
Classe NICE
10 - Appareils et instruments médicaux 43
09 - Appareils et instruments scientifiques et électriques 13
42 - Services scientifiques, technologiques et industriels, recherche et conception 13
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture. 13
35 - Publicité; Affaires commerciales 9
Voir plus
Statut
En Instance 46
Enregistré / En vigueur 225
  1     2     3        Prochaine page

1.

EXTERNAL NEUROSTIMULATOR

      
Numéro d'application 19665166
Statut En instance
Date de dépôt 2026-05-01
Date de la première publication 2026-09-10
Propriétaire NEVRO CORP. (USA)
Inventeur(s)
  • Dixit, Apratim
  • Tzvetanov, Ivan
  • Karamian, Cameron
  • Lin, Ivan Wei Tai

Abrégé

An external neurostimulator includes a housing including a base housing and a top housing, a power source, a pulse generator, and a first and second series of spring-loaded pins electrically coupled to the pulse generator. The top housing includes a central portion, a first side door hingedly coupled to a first side of the central portion, and a second side door hingedly coupled to a second side of the central portion. Each of the first side door and the second side door include a channel formed thereon that is configured to directly receive a proximal end portion of an implantable lead. Each channel includes a series of longitudinally spaced-apart openings formed on the first side door and the second side door, respectively. The first and second series of spring-loaded pins extend through the series of longitudinally spaced-apart openings of the channel on the first and second side doors, respectively.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/375 - Aménagements structurels, p. ex. boîtiers

2.

SYSTEMS AND METHODS FOR TREATING MOTOR DYSFUNCTION, INCLUDING BY SELECTIVELY ACTIVATING AND/OR SUPPRESSING MOTOR NEURONS AND/OR MOTOR RESPONSES

      
Numéro d'application 19649270
Statut En instance
Date de dépôt 2026-04-16
Date de la première publication 2026-08-20
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Lee, Kwan Yeop

Abrégé

The present technology is directed generally to electrical stimulation and associated systems and methods for preferentially and/or selectively activating and suppressing motor neurons and/or motor responses, such as to treat a motor dysfunction in patients. For example, in some embodiments high frequency electrical stimulation can be administered to a target neural population via an implanted signal delivery device to induce a motor response in a first muscle, and low frequency electrical stimulation can be administered to the target neural population via the same signal delivery device to induce a motor response in a second muscle that is different than the first muscle.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs

3.

EFFICIENT USE OF AN IMPLANTABLE PULSE GENERATOR BATTERY, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19542289
Statut En instance
Date de dépôt 2026-02-17
Date de la première publication 2026-06-25
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Parker, Jon
  • Foreman, Bret
  • Sutor, Jason Aaron
  • Knudsen, Sean

Abrégé

Systems and methods for the efficient use of an implantable pulse generator (IPG) battery are disclosed. A representative system for adjusting an electrical signal of an IPG associated with delivering therapy to a patient comprises a computer readable medium having instructions that cause the IPG to deliver a supply voltage at a first value, adjust the supply voltage from the first value until a threshold break occurs, and, based at least in part of the threshold break, increase the supply voltage from the second value to a third value. As therapy is delivered to the patient, the system iteratively adjusts the supply voltage to approach and reflect a variable minimum voltage needed to provide the requested current to the IPG.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/378 - Alimentation en courant électrique

4.

LONG PULSE WIDTH SPINAL CORD STIMULATION FOR TREATING AUTONOMIC NERVE DYSFUNCTION, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19391605
Statut En instance
Date de dépôt 2025-11-17
Date de la première publication 2026-06-04
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Bradley, Kerry
  • Pannu, Satinderpall Singh

Abrégé

The present technology provides systems and methods for delivering electrical stimulation having relatively long pulse widths to a patient’s spinal cord region to treat autonomic nervous system dysfunction. For example, some embodiments include delivering an electrical therapy signal having individual pulses with pulse widths of between about 2 milliseconds and about 10 seconds. The electrical therapy signals may treat autonomic nervous system dysfunction by normalizing activity of the patient’s parasympathetic nervous system, normalizing activity of the patient’s sympathetic nervous system, and/or normalizing a balance of activity between the patient’s parasympathetic and sympathetic nervous systems.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

5.

SYSTEMS AND METHODS FOR DIRECT SUPPRESSION OF NERVE CELLS

      
Numéro d'application 19383987
Statut En instance
Date de dépôt 2025-11-10
Date de la première publication 2026-06-04
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Bradley, Kerry
  • Lee, Dongchul

Abrégé

The present technology provides systems and methods for directly suppressing nerve cells by delivering electrical stimulation having relatively long pulse widths and at amplitudes below an activation threshold of the nerve cells. For example, some embodiments include delivering a therapy signal having individual pulses with pulse widths of between about 5 ms and 100 ms. Directly suppressing the nerve cells is expected to reduce the transmission of pain signals.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

6.

MODIFIED HIGH FREQUENCY NEUROMODULATION SIGNALS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19465612
Statut En instance
Date de dépôt 2026-01-30
Date de la première publication 2026-06-04
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry

Abrégé

The present technology is directed generally to spinal cord modulation and associated systems and methods for treating pain and other patient conditions. In particular, the present technology includes modified high frequency neuromodulation signals and administration patterns.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

7.

LONG PULSE WIDTH SPINAL CORD STIMULATION FOR TREATING AUTONOMIC NERVE DYSFUNCTION, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19389723
Statut En instance
Date de dépôt 2025-11-14
Date de la première publication 2026-05-21
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Bradley, Kerry
  • Pannu, Satinderpall Singh

Abrégé

The present technology provides systems and methods for delivering electrical stimulation having relatively long pulse widths to a patient’s spinal cord region to treat autonomic nervous system dysfunction. For example, some embodiments include delivering an electrical therapy signal having individual pulses with pulse widths of between about 2 milliseconds and about 10 seconds. The electrical therapy signals may treat autonomic nervous system dysfunction by normalizing activity of the patient’s parasympathetic nervous system, normalizing activity of the patient’s sympathetic nervous system, and/or normalizing a balance of activity between the patient’s parasympathetic and sympathetic nervous systems.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

8.

LONG PULSE WIDTH SPINAL CORD STIMULATION FOR TREATING AUTONOMIC NERVE DYSFUNCTION, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19391577
Statut En instance
Date de dépôt 2025-11-17
Date de la première publication 2026-05-21
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Bradley, Kerry
  • Pannu, Satinderpall Singh

Abrégé

The present technology provides systems and methods for delivering electrical stimulation having relatively long pulse widths to a patient’s spinal cord region to treat autonomic nervous system dysfunction. For example, some embodiments include delivering an electrical therapy signal having individual pulses with pulse widths of between about 2 milliseconds and about 10 seconds. The electrical therapy signals may treat autonomic nervous system dysfunction by normalizing activity of the patient’s parasympathetic nervous system, normalizing activity of the patient’s sympathetic nervous system, and/or normalizing a balance of activity between the patient’s parasympathetic and sympathetic nervous systems.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

9.

SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION TO INCREASE BLOOD GLUCOSE UPTAKE IN A PATIENT

      
Numéro d'application 19367104
Statut En instance
Date de dépôt 2025-10-23
Date de la première publication 2026-04-30
Propriétaire Nevro Corp. (USA)
Inventeur(s) Bradley, Kerry

Abrégé

The present technology is directed to managing blood glucose levels in patients and associated systems and methods. For example, the present technology provides a method for decreasing blood glucose levels in patients by delivering electrical signals to a spinal column of the patient via an implanted signal delivery device. The stimulation induces motor contractions in the lower extremity or abdomen, thus causing glucose uptake from the bloodstream in an insulin-independent manner.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

10.

SELECTIVE HIGH FREQUENCY SPINAL CORD MODULATION FOR INHIBITING PAIN, INCLUDING CEPHALIC AND/OR TOTAL BODY PAIN WITH REDUCED SIDE EFFECTS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19413202
Statut En instance
Date de dépôt 2025-12-09
Date de la première publication 2026-04-02
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Thacker, James R.
  • Alataris, Konstantinos
  • Gliner, Bradford Evan

Abrégé

Selective high-frequency spinal chord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region from an epidural, cervical location to address at least one of high back pain, mid-back pain, low back pain, and leg pain without creating paresthesia in the patient.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/06 - Électrodes pour traitement à haute fréquence

11.

System for Sacroiliac Joint Fusion

      
Numéro d'application 19406146
Statut En instance
Date de dépôt 2025-12-02
Date de la première publication 2026-03-26
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Black, Michael
  • Heinz, Damian

Abrégé

A surgical system for preparing the sacroiliac (SI) joint for a fusion, comprising a sliding joint finder and a working cannula. The working cannula comprises a body having a central axis that runs the length of the body. The body of the working cannula comprises a distal end, a proximal end and a central cavity that is positioned along the central axis of the working cannula and has suitable dimensions for sliding the working cannula over the sliding joint finder and the working cannula further comprises two protrusions extending proximally. In addition, the two protrusions have uneven lengths such that when the working cannula is inserted, the longer of the two protrusions engages the SI joint at a superior end of the SI joint and the shorter of the two protrusions engages the SI joint at an inferior end of the SI joint.

Classes IPC  ?

  • A61B 17/92 - Instruments à percussion ou extracteurs, p. ex. pour retirer les dispositifs intramédullaires
  • A61B 17/02 - Instruments, dispositifs ou procédés chirurgicaux pour maintenir les blessures ouvertes, p. ex. rétracteursÉcarteurs
  • A61B 17/16 - Instruments pour réaliser une ostéoclasieForets ou ciseaux pour osTrépans
  • A61B 17/17 - Dispositifs de guidage pour les forets
  • A61B 17/32 - Instruments chirurgicaux coupants
  • A61B 17/34 - TrocartsAiguilles à ponction
  • A61F 2/30 - Articulations
  • A61F 2/46 - Outils particuliers pour l'implantation des articulations artificielles

12.

POWER CONTROL CIRCUIT FOR STERILIZED DEVICES, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19398415
Statut En instance
Date de dépôt 2025-11-24
Date de la première publication 2026-03-19
Propriétaire Nevro Corp. (USA)
Inventeur(s) Foreman, Bret

Abrégé

A power control circuit for use with devices that will be placed in a flammable sterilizing gas includes a bi-stable switch that is configured to produce an output to place the circuitry of a connected device in a run state or a sleep state. The bi-stable switch controls one or more transistors to drain energy from energy storage devices in the circuitry of the connected device to a level below an ignition level of a sterilizing gas. A remotely actuatable switch can be actuated from outside of a packaging in which the power control circuit is placed to cause the bi-stable switch to produce an output that puts the circuitry in the run state without removing the power control circuit from the packaging.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

13.

ELECTRICAL THERAPY APPLIED TO THE BRAIN WITH INCREASED EFFICACY AND/OR DECREASED UNDESIRABLE SIDE EFFECTS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19363151
Statut En instance
Date de dépôt 2025-10-20
Date de la première publication 2026-02-12
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Pannu, Satinderpall Singh
  • Gliner, Bradford Evan

Abrégé

Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods, are disclosed. A representative method includes applying a therapy signal to a patient, via at least one electrode at a subdural or epidural location at the patient's brain, to provide effective therapy that reduces or eliminates the effects of a patient disorder. The therapy signal does not induce any non-therapeutic side effects, and has a frequency in a frequency range of from 1.2 kHz to 500 kHz, an amplitude in an amplitude range from 0.1 to 20 mA, and a pulse width in a pulse width range from 1 microsecond to 400 microseconds.

Classes IPC  ?

  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61B 5/291 - Électrodes bioélectriques à cet effet spécialement adaptées à des utilisations particulières pour l’électroencéphalographie [EEG]
  • A61B 5/293 - Électrodes bioélectriques à cet effet spécialement adaptées à des utilisations particulières pour l’électroencéphalographie [EEG] invasives
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

14.

IMPLANTED PULSE GENERATORS WITH REDUCED POWER CONSUMPTION VIA SIGNAL STRENGTH/DURATION CHARACTERISTICS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19357730
Statut En instance
Date de dépôt 2025-10-14
Date de la première publication 2026-02-05
Propriétaire Nevro Corp. (USA)
Inventeur(s) Parker, Jon

Abrégé

Implanted pulse generators with reduced power consumption via signal strength-duration characteristics, and associated systems and methods are disclosed. A representative method for treating a patient in accordance with the disclosed technology includes receiving an input corresponding to an available voltage for an implanted medical device and identifying a signal delivery parameter value of an electrical signal based on a correlation between values of the signal delivery parameter and signal delivery amplitudes. The signal delivery parameter can include at least one of pulse width or duty cycle. The method can further include delivering an electrical therapy signal to the patient at the identified signal delivery parameter value using a voltage within a margin of the available voltage.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/37 - SurveillanceProtection

15.

AUTONOMIC NERVOUS SYSTEM CONTROL VIA HIGH FREQUENCY SPINAL CORD MODULATION, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19332748
Statut En instance
Date de dépôt 2025-09-18
Date de la première publication 2026-01-15
Propriétaire Nevro Corp. (USA)
Inventeur(s) Gliner, Bradford Evan

Abrégé

Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods. A method for treating a patient in accordance with a particular embodiment includes selecting a neural modulation site to include a neural population of the patient's spinal cord, and selecting parameters of a neural modulation signal to at least reduce an autonomic system deficit in the patient.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

16.

SENSORY THRESHOLD AND/OR ADAPTATION FOR NEUROLOGICAL THERAPY SCREENING AND/OR PARAMETER SELECTION, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19329768
Statut En instance
Date de dépôt 2025-09-16
Date de la première publication 2026-01-08
Propriétaire Nevro Corp. (USA)
Inventeur(s) Lee, Dongchul

Abrégé

Systems and methods for using sensory threshold and/or adaptation for neurological therapy screening and/or parameter selection. A representative method for establishing a treatment regimen for a patient includes: in response to a first indication of a characteristic of the patient's sensory response to an electrical stimulus, providing a second indication indicating suitability of an electrical signal for delivery to the patient to address a patient condition, wherein the electrical signal has a frequency in a frequency range from 1.2 kHz to 100 kHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
  • G16H 40/60 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux

17.

SYSTEMS AND METHODS FOR DETECTING FAULTS AND/OR ADJUSTING ELECTRICAL THERAPY BASED ON IMPEDANCE CHANGES

      
Numéro d'application 19302897
Statut En instance
Date de dépôt 2025-08-18
Date de la première publication 2025-12-04
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Parker, Jon
  • Walker, Andre B.
  • Singh, Udai

Abrégé

System and methods for detecting impedance changes and for adjusting electrical therapy based on impedance changes are disclosed herein. A method in accordance with a particular embodiment includes applying a therapeutic, paresthesia-less electrical signal to a patient via a patient modulation system that includes a signal delivery device in electrical communication with a target neural population of the patient. The method can include monitoring on a periodic basis an impedance of an electrical circuit that includes the signal delivery device. The method can further include detecting a change in the impedance that indicates a fault and providing an indication that the fault exists.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

18.

SPINAL CORD MODULATION FOR INHIBITING PAIN VIA SHORT PULSE WIDTH WAVEFORMS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19277935
Statut En instance
Date de dépôt 2025-07-23
Date de la première publication 2025-11-13
Propriétaire Nevro Corp. (USA)
Inventeur(s) Park, Sangsoo Wesley

Abrégé

Short pulse width spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, modulation signal has pulse widths in the range of from about 10 microseconds to about 50 microseconds may be applied to the patient's spinal cord region to address chronic pain without using paresthesia or tingling to mask or cover the patient's sensation of pain. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

19.

NEUROSTIMULATION FOR TREATING SENSORY DEFICITS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19238870
Statut En instance
Date de dépôt 2025-06-16
Date de la première publication 2025-10-02
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry
  • Lee, Kwan Yeop

Abrégé

Stimulation for treating sensory deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 200 Hz to 100 kHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

20.

NEUROSTIMULATION FOR TREATING SENSORY DEFICITS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19239029
Statut En instance
Date de dépôt 2025-06-16
Date de la première publication 2025-10-02
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry
  • Lee, Kwan Yeop

Abrégé

Stimulation for treating sensory deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 200 Hz to 100 kHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

21.

Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods

      
Numéro d'application 17579811
Numéro de brevet 12420098
Statut Délivré - en vigueur
Date de dépôt 2022-01-20
Date de la première publication 2025-09-23
Date d'octroi 2025-09-23
Propriétaire Nevro Corp. (USA)
Inventeur(s) Gliner, Bradford Evan

Abrégé

Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods. A method for treating a patient in accordance with a particular embodiment includes selecting a neural modulation site to include a neural population of the patient's spinal cord, and selecting parameters of a neural modulation signal to at least reduce an autonomic system deficit in the patient.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

22.

APPARATUS AND METHOD FOR FORMING A SUBCUTAENOUS POCKET

      
Numéro d'application US2025017906
Numéro de publication 2025/184547
Statut Délivré - en vigueur
Date de dépôt 2025-02-28
Date de publication 2025-09-04
Propriétaire NEVRO CORP. (USA)
Inventeur(s)
  • Lin, Ivan Wei Tai
  • Wong, Mark Steven
  • Chang, Katarina
  • Schieve, Keegan

Abrégé

A device may include a handle extending from a proximal end to a distal end, and include a spoon extending from the distal end of the handle, the spoon having an arm having a first width and a head having a second width, wherein the second width is substantially equal to a width of the implant device. The device may include a blunt edge defining a distal end of the spoon configured to separate tissue. The device may further include a guide extending from the handle, wherein the guide is vertically offset from the spoon.

Classes IPC  ?

23.

Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods

      
Numéro d'application 17739653
Numéro de brevet 12390645
Statut Délivré - en vigueur
Date de dépôt 2022-05-09
Date de la première publication 2025-08-19
Date d'octroi 2025-08-19
Propriétaire Nevro Corp. (USA)
Inventeur(s) Park, Sangsoo Wesley

Abrégé

Short pulse width spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, modulation signal has pulse widths in the range of from about 10 microseconds to about 50 microseconds may be applied to the patient's spinal cord region to address chronic pain without using paresthesia or tingling to mask or cover the patient's sensation of pain. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

24.

SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION TO INDUCE A STATE OF REMISSION IN A PATIENT

      
Numéro d'application US2025011172
Numéro de publication 2025/151770
Statut Délivré - en vigueur
Date de dépôt 2025-01-10
Date de publication 2025-07-17
Propriétaire NEVRO CORP. (USA)
Inventeur(s) Pannu, Satinderpall, Singh

Abrégé

The present technology is directed generally to electrical stimulation and associated systems and methods. For example, the present technology provides stimulation schedules/regimens that are expected to reduce the amount of power required for paresthesia-free stimulation, while maintaining the benefits of paresthesia- free stimulation. This is accomplished by reducing the dose of paresthesia-free neurostimulation provided to a patient over time. The dose can be reduced without a corresponding reduction, or significant reduction, in effectiveness.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre

25.

METHODS AND SYSTEMS FOR DISEASE TREATMENT USING ELECTRICAL STIMULATION

      
Numéro d'application 19086080
Statut En instance
Date de dépôt 2025-03-20
Date de la première publication 2025-07-03
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Heit, Gary
  • Gliner, Bradford Evan

Abrégé

Systems for disease treatment using electrical stimulation are disclosed. A representative method for treating a patient includes changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient by applying to a target neural population of the patient an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 KHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

26.

HIGH FREQUENCY STIMULATION FOR TREATING SENSORY AND/OR MOTOR DEFICITS IN PATIENTS WITH SPINAL CORD INJURIES AND/OR PERIPHERAL POLYNEUROPATHY, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 19017017
Statut En instance
Date de dépôt 2025-01-10
Date de la première publication 2025-06-26
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Subbaroyan, Jeyakumar
  • Bradley, Kerry
  • Lee, Dongchul

Abrégé

High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction and/or motor dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 1.5 kHz to 100 KHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs

27.

NEUROSTIMULATION WAVEFORMS HAVING A BASE COMPONENT AND A HIGH FREQUENCY COMPONENT, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 18906025
Statut En instance
Date de dépôt 2024-10-03
Date de la première publication 2025-03-27
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry

Abrégé

The present technology provides systems and methods for directly suppressing nerve cells by delivering electrical stimulation having relatively long pulse widths and at amplitudes below an activation threshold of the nerve cells. For example, some embodiments include delivering a therapy signal having individual pulses with pulse widths of between about 5 ms and 100 ms. Directly suppressing the nerve cells is expected to reduce the transmission of pain signals.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

28.

DYNAMIS

      
Numéro de série 99068563
Statut En instance
Date de dépôt 2025-03-05
Propriétaire Nevro Corp. (USA)
Classes de Nice  ? 10 - Appareils et instruments médicaux

Produits et services

Medical and surgical instruments and apparatus and components therefor, namely, devices for use in tissue and neural tissue for modulating neurological signals; medical device for use in tissue and neural tissue for modulating neurological signals for pain control; electrical neuromodulation therapy device for pain control; medical device, namely, an electrical stimulation device for stimulating nerves or neural tissue for pain control; medical device, namely, an implantable electrical stimulation device for pain control

29.

HFX DYNAMIS

      
Numéro de série 99068547
Statut En instance
Date de dépôt 2025-03-05
Propriétaire Nevro Corp. (USA)
Classes de Nice  ? 10 - Appareils et instruments médicaux

Produits et services

Medical and surgical instruments and apparatus and components therefor, namely, devices for use in tissue and neural tissue for modulating neurological signals; medical device for use in tissue and neural tissue for modulating neurological signals for pain control; electrical neuromodulation therapy device for pain control; medical device, namely, an electrical stimulation device for stimulating nerves or neural tissue for pain control; medical device, namely, an implantable electrical stimulation device for pain control

30.

Treatment of neurodegenerative disease with high frequency stimulation, and associated systems and methods

      
Numéro d'application 18747310
Numéro de brevet 12661516
Statut Délivré - en vigueur
Date de dépôt 2024-06-18
Date de la première publication 2025-02-13
Date d'octroi 2026-06-23
Propriétaire Nevro Corporation (USA)
Inventeur(s)
  • Thacker, James R.
  • Bradley, Kerry
  • Lee, Dongchul

Abrégé

Systems and methods for treating neurodegenerative disorders with high frequency stimulation are disclosed. A representative method for treating a patient includes applying an electrical signal to the patient via a treatment system that includes a signal delivery element positioned at or within a white matter of the patient's brain, spinal cord, or both, the electrical signal having a frequency of from about 1.5 kHz to about 100 kHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/06 - Électrodes pour traitement à haute fréquence

31.

Neurostimulation for treating sensory deficits, and associated systems and methods

      
Numéro d'application 18637299
Numéro de brevet 12343537
Statut Délivré - en vigueur
Date de dépôt 2024-04-16
Date de la première publication 2025-02-06
Date d'octroi 2025-07-01
Propriétaire Nevro Corporation (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry
  • Lee, Kwan Yeop

Abrégé

Stimulation for treating sensory deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 200 Hz to 100 KHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

32.

SYSTEMS AND METHODS FOR CONCURRENTLY DELIVERING HIGH FREQUENCY AND LONG PULSE WIDTH ELECTRICAL STIMULATION

      
Numéro d'application 18916512
Statut En instance
Date de dépôt 2024-10-15
Date de la première publication 2025-01-30
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry

Abrégé

The present technology is directed generally to electrical stimulation and associated systems and methods. For example, in some embodiments a first electrical signal can be applied to a target neural population via two or more electrodes on a signal delivery element, and a second electrical signal can be applied to two or more different electrodes on the signal delivery element. The first electrical signal and the second electrical signal can have different parameters. For example, the first electrical signal can have a frequency under 1.2 kHz and the second electrical signal can have a frequency greater than 1.2 kHz. In some embodiments, the first electrical signal has a relatively long pulse width, such as between about 5 milliseconds and about 2 seconds, such that it approximates a direct current signal.

Classes IPC  ?

  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

33.

Variable amplitude signals for neurological therapy, and associated systems and methods

      
Numéro d'application 18595224
Numéro de brevet 12220580
Statut Délivré - en vigueur
Date de dépôt 2024-03-04
Date de la première publication 2024-12-26
Date d'octroi 2025-02-11
Propriétaire Nevro Corp. (USA)
Inventeur(s) Dawson, Chris

Abrégé

Variable amplitude signals for neurological therapy, and associated systems and methods are disclosed. A representative method includes activating automatic delivery of an electrical therapy signal to a patient's spinal cord region at a frequency in a frequency range between 1.5 kHz and 100 kHz, via at least one signal delivery contact carried by an implanted signal delivery device. The delivery can include repeatedly and automatically delivering the electrical therapy signal at each of multiple therapy signal amplitudes to the at least one signal delivery contact, without the therapy signal generating paresthesia in the patient. The foregoing process can be used as a screening tool to screen responders from non-responders in the context of a non-paresthesia-generating therapy, and/or can be used during long-term treatment, for example, for chronic pain.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

34.

Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods

      
Numéro d'application 18590912
Numéro de brevet 12447333
Statut Délivré - en vigueur
Date de dépôt 2024-02-28
Date de la première publication 2024-12-05
Date d'octroi 2025-10-21
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Pannu, Satinderpall Singh
  • Gliner, Bradford Evan

Abrégé

Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods, are disclosed. A representative method includes applying a therapy signal to a patient, via at least one electrode at a subdural or epidural location at the patient's brain, to provide effective therapy that reduces or eliminates the effects of a patient disorder. The therapy signal does not induce any non-therapeutic side effects, and has a frequency in a frequency range of from 1.2 kHz to 500 kHz, an amplitude in an amplitude range from 0.1 to 20 mA, and a pulse width in a pulse width range from 1 microsecond to 400 microseconds.

Classes IPC  ?

  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61B 5/293 - Électrodes bioélectriques à cet effet spécialement adaptées à des utilisations particulières pour l’électroencéphalographie [EEG] invasives
  • A61N 1/08 - Aménagements ou circuits de surveillance, de protection, de commande ou d'indication
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61B 5/291 - Électrodes bioélectriques à cet effet spécialement adaptées à des utilisations particulières pour l’électroencéphalographie [EEG]

35.

SYSTEMS AND METHODS FOR TREATING MOTOR DYSFUNCTION, INCLUDING BY SELECTIVELY ACTIVATING AND/OR SUPPRESSING MOTOR NEURONS AND/OR MOTOR RESPONSES

      
Numéro d'application 18664524
Statut En instance
Date de dépôt 2024-05-15
Date de la première publication 2024-11-28
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Lee, Kwan Yeop

Abrégé

The present technology is directed generally to electrical stimulation and associated systems and methods for preferentially and/or selectively activating and suppressing motor neurons and/or motor responses, such as to treat a motor dysfunction in patients. For example, in some embodiments high frequency electrical stimulation can be administered to a target neural population via an implanted signal delivery device to induce a motor response in a first muscle, and low frequency electrical stimulation can be administered to the target neural population via the same signal delivery device to induce a motor response in a second muscle that is different than the first muscle.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs

36.

LONG PULSE WIDTH SPINAL CORD STIMULATION FOR TREATING DIABETIC NEUROPATHY, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application US2024028654
Numéro de publication 2024/233824
Statut Délivré - en vigueur
Date de dépôt 2024-05-09
Date de publication 2024-11-14
Propriétaire NEVRO CORP. (USA)
Inventeur(s) Bradley, Kerry

Abrégé

The present technology provides systems and methods for delivering electrical stimulation having relatively long pulse widths to treat patient neuropathies, including diabetic neuropathy. For example, some embodiments include delivering a therapy signal having individual pulses with pulse widths of between about 5 milliseconds and 2 seconds. The therapy signals may restore sensation lost in association with the diabetic neuropathy and/or reduce pain or other abnormal sensations associated with the diabetic neuropathy.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

37.

SYSTEMS AND METHODS FOR PRODUCING ASYNCHRONOUS NEURAL RESPONSES TO TREAT PAIN AND/OR OTHER PATIENT CONDITIONS

      
Numéro d'application 18531474
Statut En instance
Date de dépôt 2023-12-06
Date de la première publication 2024-11-07
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Walker, Andre B.
  • Fang, Zi-Ping
  • Caparso, Anthony V.

Abrégé

Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions are disclosed. A method in accordance with a particular embodiment includes selecting a target stimulation frequency that is above a threshold frequency, with the threshold frequency corresponding to a refractory period for neurons of a target sensory neural population. The method can further include producing a patient sensation of paresthesia by directing an electrical signal to multiple sensory neurons of the target sensory neural population at the stimulation frequency, with individual neurons of the sensory neural population completing corresponding individual refractory periods at different times, resulting in an asynchronous sensory neuron response to the electrical signal.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs

38.

Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods

      
Numéro d'application 18531570
Numéro de brevet 12491365
Statut Délivré - en vigueur
Date de dépôt 2023-12-06
Date de la première publication 2024-10-31
Date d'octroi 2025-12-09
Propriétaire Nevro, Corp. (USA)
Inventeur(s)
  • Thacker, James R.
  • Alataris, Konstantinos
  • Gliner, Bradford Evan

Abrégé

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region from an epidural, cervical location to address at least one of high back pain, mid-back pain, low back pain, and leg pain without creating paresthesia in the patient.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/06 - Électrodes pour traitement à haute fréquence

39.

Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods

      
Numéro d'application 17967805
Numéro de brevet 12102820
Statut Délivré - en vigueur
Date de dépôt 2022-10-17
Date de la première publication 2024-10-01
Date d'octroi 2024-10-01
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Pannu, Satinderpall Singh
  • Gliner, Bradford Evan

Abrégé

Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods, are disclosed. A representative method includes applying a therapy signal to a patient, via at least one electrode at a subdural or epidural location at the patient's brain, to provide effective therapy that reduces or eliminates the effects of a patient disorder. The therapy signal does not induce any non-therapeutic side effects, and has a frequency in a frequency range of from 1.2 kHz to 500 kHz, an amplitude in an amplitude range from 0.1 to 20 mA, and a pulse width in a pulse width range from 1 microsecond to 400 microseconds.

Classes IPC  ?

  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61B 5/291 - Électrodes bioélectriques à cet effet spécialement adaptées à des utilisations particulières pour l’électroencéphalographie [EEG]

40.

Methods and systems for disease treatment using electrical stimulation

      
Numéro d'application 18622434
Numéro de brevet 12280256
Statut Délivré - en vigueur
Date de dépôt 2024-03-29
Date de la première publication 2024-07-18
Date d'octroi 2025-04-22
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Heit, Gary
  • Gliner, Bradford Evan

Abrégé

Systems for disease treatment using electrical stimulation are disclosed. A representative method for treating a patient includes changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient by applying to a target neural population of the patient an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 KHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

41.

SELECTIVE HIGH FREQUENCY SPINAL CORD MODULATION FOR INHIBITING PAIN WITH REDUCED SIDE EFFECTS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 18444209
Statut En instance
Date de dépôt 2024-02-16
Date de la première publication 2024-06-06
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Alataris, Konstantinos
  • Walker, Andre B.
  • Parker, Jon
  • Chitre, Yougandh
  • Park, Sangsoo Wesley
  • Thacker, James R.

Abrégé

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region to address low back pain without creating unwanted sensory and/or motor side effects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/06 - Électrodes pour traitement à haute fréquence
  • A61N 1/32 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
  • A61N 1/378 - Alimentation en courant électrique
  • G01R 21/133 - Dispositions pour procéder aux mesures de la puissance ou du facteur de puissance en utilisant des techniques numériques

42.

Methods and systems for disease treatment using electrical stimulation

      
Numéro d'application 16922304
Numéro de brevet 11998744
Statut Délivré - en vigueur
Date de dépôt 2020-07-07
Date de la première publication 2024-06-04
Date d'octroi 2024-06-04
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Heit, Gary
  • Gliner, Bradford Evan

Abrégé

Systems for disease treatment using electrical stimulation are disclosed. A representative method for treating a patient includes changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient by applying to a target neural population of the patient an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

43.

Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods

      
Numéro d'application 18452485
Numéro de brevet 12440676
Statut Délivré - en vigueur
Date de dépôt 2023-08-18
Date de la première publication 2024-05-30
Date d'octroi 2025-10-14
Propriétaire NEVRO CORP. (USA)
Inventeur(s) Parker, Jon

Abrégé

Implanted pulse generators with reduced power consumption via signal strength-duration characteristics, and associated systems and methods are disclosed. A representative method for treating a patient in accordance with the disclosed technology includes receiving an input corresponding to an available voltage for an implanted medical device and identifying a signal delivery parameter value of an electrical signal based on a correlation between values of the signal delivery parameter and signal deliver amplitudes. The signal deliver parameter can include at least one of pulse width or duty cycle. The method can further include delivering an electrical therapy signal to the patient at the identified signal delivery parameter value using a voltage within a margin of the available voltage.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/37 - SurveillanceProtection

44.

NEVRO1

      
Numéro de série 98554878
Statut En instance
Date de dépôt 2024-05-16
Propriétaire Nevro Corp. (USA)
Classes de Nice  ? 10 - Appareils et instruments médicaux

Produits et services

Medical device, namely, an implant made of artificial materials used to stabilize the sacroiliac joint

45.

NEVROPRO

      
Numéro de série 98554882
Statut En instance
Date de dépôt 2024-05-16
Propriétaire Nevro Corp. (USA)
Classes de Nice  ? 10 - Appareils et instruments médicaux

Produits et services

Medical device, namely, an implant made of artificial materials used to stabilize the sacroiliac joint

46.

NEVROFIX

      
Numéro de série 98554888
Statut En instance
Date de dépôt 2024-05-16
Propriétaire Nevro Corp. (USA)
Classes de Nice  ? 10 - Appareils et instruments médicaux

Produits et services

Medical device, namely, an implant made of artificial materials used to stabilize the sacroiliac joint

47.

Systems and methods for direct suppression of nerve cells

      
Numéro d'application 18486338
Numéro de brevet 12465767
Statut Délivré - en vigueur
Date de dépôt 2023-10-13
Date de la première publication 2024-05-02
Date d'octroi 2025-11-11
Propriétaire NEVRO CORP. (USA)
Inventeur(s)
  • Bradley, Kerry
  • Lee, Dongchul

Abrégé

The present technology provides systems and methods for directly suppressing nerve cells by delivering electrical stimulation having relatively long pulse widths and at amplitudes below an activation threshold of the nerve cells. For example, some embodiments include delivering a therapy signal having individual pulses with pulse widths of between about 5 ms and 100 ms. Directly suppressing the nerve cells is expected to reduce the transmission of pain signals.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

48.

SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION, INCLUDING MAINTENANCE DOSES OF NEUROSTIMULATION FOR MAINTAINING A PATIENT IN A STATE OF REMISSION

      
Numéro d'application US2023077456
Numéro de publication 2024/086818
Statut Délivré - en vigueur
Date de dépôt 2023-10-20
Date de publication 2024-04-25
Propriétaire NEVRO CORP. (USA)
Inventeur(s) Pannu, Satinderpall, Singh

Abrégé

The present technology is directed generally to electrical stimulation and associated systems and methods. For example, the present technology provides stimulation schedules/regimens that are expected to reduce the amount of power required for paresthesia-free stimulation, while maintaining the benefits of paresthesia-free stimulation. This is accomplished by reducing the dose of paresthesia-free neurostimulation provided to a patient over time. The dose can be reduced without a corresponding reduction, or significant reduction, in effectiveness.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

49.

Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods

      
Numéro d'application 17387375
Numéro de brevet 11944811
Statut Délivré - en vigueur
Date de dépôt 2021-07-28
Date de la première publication 2024-04-02
Date d'octroi 2024-04-02
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Pannu, Satinderpall Singh
  • Gliner, Bradford Evan

Abrégé

Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods, are disclosed. A representative method includes applying a therapy signal to a patient, via at least one electrode at a subdural or epidural location at the patient's brain, to provide effective therapy that reduces or eliminates the effects of a patient disorder. The therapy signal does not induce any non-therapeutic side effects, and has a frequency in a frequency range of from 1.2 kHz to 500 kHz, an amplitude in an amplitude range from 0.1 to 20 mA, and a pulse width in a pulse width range from 1 microsecond to 400 microseconds.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/08 - Aménagements ou circuits de surveillance, de protection, de commande ou d'indication
  • A61B 5/291 - Électrodes bioélectriques à cet effet spécialement adaptées à des utilisations particulières pour l’électroencéphalographie [EEG]

50.

Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods

      
Numéro d'application 18366619
Numéro de brevet 12285611
Statut Délivré - en vigueur
Date de dépôt 2023-08-07
Date de la première publication 2024-01-25
Date d'octroi 2025-04-29
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Alataris, Konstantinos
  • Walker, Andre B.
  • Parker, Jon

Abrégé

Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods are disclosed. A representative method in accordance with an embodiment of the disclosure includes creating a therapeutic effect and a sensation in a patient by delivering to the patient first pulses having a first set of first signal delivery parameters and second pulses having a second set of second signal delivery parameters, wherein a first value of at least one first parameter of the first set is different than a second value of a corresponding second parameter of the second set, and wherein the first pulses, the second pulses or both the first and second pulses are delivered to the patient's spinal cord.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/06 - Électrodes pour traitement à haute fréquence

51.

SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION, INCLUDING REDUCED DOSES OF NEUROSTIMULATION

      
Numéro d'application 18352846
Statut En instance
Date de dépôt 2023-07-14
Date de la première publication 2024-01-18
Propriétaire Nevro Corp. (USA)
Inventeur(s) Pannu, Satinderpall Singh

Abrégé

The present technology is directed generally to electrical stimulation and associated systems and methods. For example, the present technology provides stimulation schedules/regimens that are expected to reduce the amount of power required for paresthesia-free stimulation, while maintaining the benefits of paresthesia-free stimulation. This is accomplished by reducing the dose of paresthesia-free neurostimulation provided to a patient over time. The dose can be reduced without a corresponding reduction, or significant reduction, in effectiveness.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

52.

Power control circuit for sterilized devices, and associated systems and methods

      
Numéro d'application 18106297
Numéro de brevet 12478784
Statut Délivré - en vigueur
Date de dépôt 2023-02-06
Date de la première publication 2024-01-18
Date d'octroi 2025-11-25
Propriétaire Nevro Corp. (USA)
Inventeur(s) Foreman, Bret

Abrégé

A power control circuit for use with devices that will be placed in a flammable sterilizing gas includes a bi-stable switch that is configured to produce an output to place the circuitry of a connected device in a run state or a sleep state. The bi-stable switch controls one or more transistors to drain energy from energy storage devices in the circuitry of the connected device to a level below an ignition level of a sterilizing gas. A remotely actuatable switch can be actuated from outside of a packaging in which the power control circuit is placed to cause the bi-stable switch to produce an output that puts the circuitry in the run state without removing the power control circuit from the packaging.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

53.

SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION, INCLUDING REDUCED DOSES OF NEUROSTIMULATION

      
Numéro d'application US2023070250
Numéro de publication 2024/015987
Statut Délivré - en vigueur
Date de dépôt 2023-07-14
Date de publication 2024-01-18
Propriétaire NEVRO CORP. (USA)
Inventeur(s) Pannu, Satinderpall, Singh

Abrégé

The present technology is directed generally to electrical stimulation and associated systems and methods. For example, the present technology provides stimulation schedules/regimens that are expected to reduce the amount of power required for paresthesia-free stimulation, while maintaining the benefits of paresthesia- free stimulation. This is accomplished by reducing the dose of paresthesia-free neurostimulation provided to a patient over time. The dose can be reduced without a corresponding reduction, or significant reduction, in effectiveness.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/378 - Alimentation en courant électrique
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

54.

APPLICATOR FOR EXTERNAL WEARABLE DEVICE

      
Numéro d'application US2023069633
Numéro de publication 2024/011122
Statut Délivré - en vigueur
Date de dépôt 2023-07-05
Date de publication 2024-01-11
Propriétaire NEVRO CORP. (USA)
Inventeur(s)
  • Dixit, Apratim
  • Tzvetanov, Ivan
  • Goor, Jared

Abrégé

An applicator for applying an external wearable device to a target skin location, the external wearable device having an adhesive layer coupled thereto. The applicator includes an actuator and a plurality of claws configured to receive the external wearable device when in a retracted state. Actuation of the actuator from a first position to a second position causes the plurality of claws to transition from the retracted state to an extended state. The actuator in the second position also places an axial force onto the external wearable device as to press the adhesive layer of the external wearable device onto the target skin location.

Classes IPC  ?

  • A61N 1/04 - Électrodes
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

55.

Neurostimulation for treating sensory deficits, and associated systems and methods

      
Numéro d'application 18344579
Numéro de brevet 11986657
Statut Délivré - en vigueur
Date de dépôt 2023-06-29
Date de la première publication 2024-01-04
Date d'octroi 2024-05-21
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry
  • Lee, Kwan Yeop

Abrégé

Stimulation for treating sensory deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 200 Hz to 100 kHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

56.

NEUROSTIMULATION FOR TREATING SENSORY DEFICITS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application US2023069368
Numéro de publication 2024/006905
Statut Délivré - en vigueur
Date de dépôt 2023-06-29
Date de publication 2024-01-04
Propriétaire NEVRO CORP. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry
  • Lee, Kwan, Yeop

Abrégé

Stimulation for treating sensory deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 200 Hz to 100 kHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

57.

System for sacroiliac joint fusion

      
Numéro d'application 18329231
Numéro de brevet 12484945
Statut Délivré - en vigueur
Date de dépôt 2023-06-05
Date de la première publication 2023-12-07
Date d'octroi 2025-12-02
Propriétaire NEVRO CORP. (USA)
Inventeur(s)
  • Black, Michael
  • Heinz, Damian

Abrégé

A surgical system for preparing the sacroiliac (SI) joint for a fusion, comprising a sliding joint finder and a working cannula. The working cannula comprises a body having a central axis that runs the length of the body. The body of the working cannula comprises a distal end, a proximal end and a central cavity that is positioned along the central axis of the working cannula and has suitable dimensions for sliding the working cannula over the sliding joint finder and the working cannula further comprises two protrusions extending proximally. In addition, the two protrusions have uneven lengths such that when the working cannula is inserted, the longer of the two protrusions engages the SI joint at a superior end of the SI joint and the shorter of the two protrusions engages the SI joint at an inferior end of the SI joint.

Classes IPC  ?

  • A61B 17/02 - Instruments, dispositifs ou procédés chirurgicaux pour maintenir les blessures ouvertes, p. ex. rétracteursÉcarteurs
  • A61B 17/16 - Instruments pour réaliser une ostéoclasieForets ou ciseaux pour osTrépans
  • A61B 17/17 - Dispositifs de guidage pour les forets
  • A61B 17/34 - TrocartsAiguilles à ponction
  • A61B 17/92 - Instruments à percussion ou extracteurs, p. ex. pour retirer les dispositifs intramédullaires
  • A61F 2/46 - Outils particuliers pour l'implantation des articulations artificielles
  • A61B 17/32 - Instruments chirurgicaux coupants
  • A61F 2/30 - Articulations

58.

Efficient use of an implantable pulse generator battery, and associated systems and methods

      
Numéro d'application 18118671
Numéro de brevet 12551705
Statut Délivré - en vigueur
Date de dépôt 2023-03-07
Date de la première publication 2023-11-02
Date d'octroi 2026-02-17
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Parker, Jon
  • Foreman, Bret
  • Sutor, Jason Aaron
  • Knudsen, Sean

Abrégé

Systems and methods for the efficient use of an implantable pulse generator (IPG) battery are disclosed. A representative system for adjusting an electrical signal of an IPG associated with delivering therapy to a patient comprises a computer readable medium having instructions that cause the IPG to deliver a supply voltage at a first value, adjust the supply voltage from the first value until a threshold break occurs, and, based at least in part of the threshold break, increase the supply voltage from the second value to a third value. As therapy is delivered to the patient, the system iteratively adjusts the supply voltage to approach and reflect a variable minimum voltage needed to provide the requested current to the IPG.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/378 - Alimentation en courant électrique

59.

SYSTEMS AND METHODS FOR CONCURRENTLY DELIVERING HIGH FREQUENCY AND LONG PULSE WIDTH ELECTRICAL STIMULATION

      
Numéro d'application US2023066215
Numéro de publication 2023/212581
Statut Délivré - en vigueur
Date de dépôt 2023-04-25
Date de publication 2023-11-02
Propriétaire NEVRO CORP. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry

Abrégé

The present technology is directed generally to electrical stimulation and associated systems and methods. For example, in some embodiments a first electrical signal can be applied to a target neural population via two or more electrodes on a signal delivery element, and a second electrical signal can be applied to two or more different electrodes on the signal delivery element. The first electrical signal and the second electrical signal can have different parameters. For example, the first electrical signal can have a frequency under 1.2 kHz and the second electrical signal can have a frequency greater than 1.2 kHz. In some embodiments, the first electrical signal has a relatively long pulse width, such as between about 5 milliseconds and about 2 seconds, such that it approximates a direct current signal.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

60.

Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods

      
Numéro d'application 17355507
Numéro de brevet 11801382
Statut Délivré - en vigueur
Date de dépôt 2021-06-23
Date de la première publication 2023-10-31
Date d'octroi 2023-10-31
Propriétaire Nevro Corp. (USA)
Inventeur(s) Zinner, Alex

Abrégé

Improving motor function in spinal cord injury patients (among others) via electrical stimulation, and associated systems and methods are disclosed. A representative method includes, in a patient having a spinal cord injury, improving the patient's gait response by delivering an electrical signal that includes repeating pulse packets delivered at a first frequency of from 2 Hz to 200 Hz. The electrical signal is delivered from an epidural location at the patient's spinal cord, and the individual pulse packets include a first period during which pulses are delivered at a first frequency of from 1 kHz to 5 kHz and a first pulse width of from 80 microseconds to 400 microseconds and a first amplitude from 0.1 mA to 20 mA, followed by a second period during which pulses are (a) not delivered, or (b) delivered at a second frequency higher than the first frequency, and/or a second pulse width shorter than the first pulse width, and/or a second amplitude less than the first amplitude.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

61.

SYSTEMS AND METHODS FOR IDENTIFYING AND TREATING PATIENTS WITH HIGH-FREQUENCY ELECTRICAL SIGNALS

      
Numéro d'application 18338285
Statut En instance
Date de dépôt 2023-06-20
Date de la première publication 2023-10-26
Propriétaire Nevro Corp. (USA)
Inventeur(s) Lee, Dongchul

Abrégé

Systems and methods for identifying and treating patients with high frequency electrical signals. A representative method for identifying a patient as a candidate for pain treatment includes identifying a first sensory threshold, delivering an electrical signal to a neural population of the patient at a frequency in a frequency range of 1.5 kHz to 100 kHz and, while and/or after delivering the electrical signal to the patient, identifying a second sensory threshold of the patient. If the second sensory threshold is less than the first, the method can include identifying the patient as a candidate for receiving an electrical signal at a frequency in the foregoing range for pain treatment.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

62.

Systems and methods for detecting faults and/or adjusting electrical therapy based on impedance changes

      
Numéro d'application 17993485
Numéro de brevet 12409324
Statut Délivré - en vigueur
Date de dépôt 2022-11-23
Date de la première publication 2023-09-21
Date d'octroi 2025-09-09
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Parker, Jon
  • Walker, Andre B.
  • Singh, Udai

Abrégé

System and methods for detecting impedance changes and for adjusting electrical therapy based on impedance changes are disclosed herein. A method in accordance with a particular embodiment includes applying a therapeutic, paresthesia-less electrical signal to a patient via a patient modulation system that includes a signal delivery device in electrical communication with a target neural population of the patient. The method can include monitoring on a periodic basis an impedance of an electrical circuit that includes the signal delivery device. The method can further include detecting a change in the impedance that indicates a fault and providing an indication that the fault exists.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

63.

TREATMENT OF CONGESTIVE HEART FAILURE WITH ELECTRICAL STIMULATION, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 18103652
Statut En instance
Date de dépôt 2023-01-31
Date de la première publication 2023-08-31
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Thacker, James R.
  • Bradley, Kerry

Abrégé

Systems and methods for treating congestive heart failure with high frequency stimulation are disclosed. A representative method for treating a patient includes applying an electrical signal having a frequency of from about 1 kHz to about 100 kHz to the patient via a treatment system that includes a signal delivery element in electrical communication with the patient's vagus nerve at a portion of the vagus nerve located at or proximate to the anterior interventricular junction of the patient's heart. The method can further include automatically detecting at least one physiological parameter of the patient, automatically determining at least one of an ejection fraction of the patient's heart and a correlate of the ejection fraction based on the detected parameter, and automatically adjusting the applied signal based on the determined ejection fraction.

Classes IPC  ?

  • A61N 1/362 - Stimulateurs cardiaques
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

64.

Variable amplitude signals for neurological therapy, and associated systems and methods

      
Numéro d'application 17900681
Numéro de brevet 11944817
Statut Délivré - en vigueur
Date de dépôt 2022-08-31
Date de la première publication 2023-08-10
Date d'octroi 2024-04-02
Propriétaire Nevro Corp. (USA)
Inventeur(s) Dawson, Chris

Abrégé

Variable amplitude signals for neurological therapy, and associated systems and methods are disclosed. A representative method includes activating automatic delivery of an electrical therapy signal to a patient's spinal cord region at a frequency in a frequency range between 1.5 kHz and 100 kHz, via at least one signal delivery contact carried by an implanted signal delivery device. The delivery can include repeatedly and automatically delivering the electrical therapy signal at each of multiple therapy signal amplitudes to the at least one signal delivery contact, without the therapy signal generating paresthesia in the patient. The foregoing process can be used as a screening tool to screen responders from non-responders in the context of a non-paresthesia-generating therapy, and/or can be used during long-term treatment, for example, for chronic pain.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

65.

HIGH FREQUENCY STIMULATION FOR TREATING SENSORY AND/OR MOTOR DEFICITS IN PATIENTS WITH SPINAL CORD INJURIES AND/OR PERIPHERAL POLYNEUROPATHY, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 18131760
Statut En instance
Date de dépôt 2023-04-06
Date de la première publication 2023-08-10
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Subbaroyan, Jeyakumar
  • Bradley, Kerry
  • Lee, Dongchul

Abrégé

High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction and/or motor dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 1.5 kHz to 100 kHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

66.

THERAPEUTIC MODULATION TO TREAT BLOOD GLUCOSE ABNORMALITIES, INCLUDING TYPE 2 DIABETES, AND/OR REDUCE HBA1C LEVELS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 17991810
Statut En instance
Date de dépôt 2022-11-21
Date de la première publication 2023-06-22
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Baldoni, Daniel
  • Pannu, Satinderpall Singh

Abrégé

Systems and methods for treating a patient having a blood glucose abnormality, such as type 2 diabetes (T2D), using an electrical signal are disclosed. A representative method for treating a patient includes, based at least in part on a patient indication of a blood glucose abnormality, positioning at least one implantable signal delivery device proximate to a target location at the patient's spinal cord within a vertebral range of from about C8 to about T12. The method further includes directing an electrical signal to the target location via the implantable signal delivery device, wherein the electrical signal has a frequency in a frequency range of from 1.2 kHz to 100 kHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

67.

HIGH FREQUENCY ELECTROMAGNETIC STIMULATION FOR MODULATING CELLS, INCLUDING SPONTANEOUSLY ACTIVE AND QUIESCENT CELLS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 17889633
Statut En instance
Date de dépôt 2022-08-17
Date de la première publication 2023-06-08
Propriétaire Nevro Corp. (USA)
Inventeur(s) Lee, Dongchul

Abrégé

Electromagnetic stimulation for treating diseases, conditions associated with diseases and/or inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency stimulation in the range of from about 1.5 kHz to about 100 kHz may be applied to a patient's target tissue region to treat the disease, associated condition and/or to inhibit pain. Electrical stimulation in accordance with similar parameters can directly affect a cellular membrane, such as a neuron and in particular, a spontaneously active neuron and/or a quiescent neuron.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/08 - Aménagements ou circuits de surveillance, de protection, de commande ou d'indication

68.

SYSTEMS AND METHODS FOR TREATING MOTOR DYSFUNCTION, INCLUDING BY SELECTIVELY ACTIVATING AND/OR SUPPRESSING MOTOR NEURONS AND/OR MOTOR RESPONSES

      
Numéro d'application US2022049958
Numéro de publication 2023/086672
Statut Délivré - en vigueur
Date de dépôt 2022-11-15
Date de publication 2023-05-19
Propriétaire NEVRO CORP. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Lee, Kwan Yeop

Abrégé

The present technology is directed generally to electrical stimulation and associated systems and methods for preferentially and/or selectively activating and suppressing motor neurons and/or motor responses, such as to treat a motor dysfunction in patients. For example, in some embodiments high frequency electrical stimulation can be administered to a target neural population via an implanted signal delivery device to induce a motor response in a first muscle, and low frequency electrical stimulation can be administered to the target neural population via the same signal delivery device to induce a motor response in a second muscle that is different than the first muscle.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

69.

External neurostimulator

      
Numéro d'application 29774995
Numéro de brevet D0984650
Statut Délivré - en vigueur
Date de dépôt 2021-03-19
Date de la première publication 2023-04-25
Date d'octroi 2023-04-25
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Dixit, Apratim
  • Tzvetanov, Ivan
  • Karamian, Cameron
  • Alsberg, Keith Daniel
  • O'Leary, Jeremiah Peter
  • Paulsen, Gary Harlan
  • Mashhadi, Omid

70.

Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods

      
Numéro d'application 17685295
Numéro de brevet 11883663
Statut Délivré - en vigueur
Date de dépôt 2022-03-02
Date de la première publication 2023-01-26
Date d'octroi 2024-01-30
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Thacker, James R.
  • Alataris, Konstantinos
  • Gliner, Bradford Evan

Abrégé

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region from an epidural, cervical location to address at least one of high back pain, mid-back pain, low back pain, and leg pain without creating paresthesia in the patient.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/06 - Électrodes pour traitement à haute fréquence

71.

Neurostimulation waveforms having a base component and a high frequency component, and associated systems and methods

      
Numéro d'application 17837726
Numéro de brevet 12133981
Statut Délivré - en vigueur
Date de dépôt 2022-06-10
Date de la première publication 2022-12-22
Date d'octroi 2024-11-05
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry

Abrégé

The present technology provides systems and methods for directly suppressing nerve cells by delivering electrical stimulation having relatively long pulse widths and at amplitudes below an activation threshold of the nerve cells. For example, some embodiments include delivering a therapy signal having individual pulses with pulse widths of between about 5 ms and 100 ms. Directly suppressing the nerve cells is expected to reduce the transmission of pain signals.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

72.

NEUROSTIMULATION WAVEFORMS HAVING A BASE COMPONENT AND A HIGH FREQUENCY COMPONENT, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application US2022033039
Numéro de publication 2022/261457
Statut Délivré - en vigueur
Date de dépôt 2022-06-10
Date de publication 2022-12-15
Propriétaire NEVRO CORP. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry

Abrégé

The present technology provides systems and methods for directly suppressing nerve cells by delivering electrical stimulation having relatively long pulse widths and at amplitudes below an activation threshold of the nerve cells. For example, some embodiments include delivering a therapy signal having individual pulses with pulse widths of between about 5 ms and 100 ms. Directly suppressing the nerve cells is expected to reduce the transmission of pain signals.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/06 - Électrodes pour traitement à haute fréquence

73.

Neurological stimulation lead anchors and associated tools, and methods

      
Numéro d'application 17846941
Numéro de brevet 12214188
Statut Délivré - en vigueur
Date de dépôt 2022-06-22
Date de la première publication 2022-12-08
Date d'octroi 2025-02-04
Propriétaire Nevro Corp. (USA)
Inventeur(s) Wong, Mark Steven

Abrégé

A lead anchor comprising a longitudinally extending anchor body and a retainer. The longitudinally extending anchor body having a lumen positioned to receive a spinal cord lead therethrough and having a retainer pocket intersecting the lumen. The retainer is positioned in the retainer pocket. The retainer comprises a first grip member having at least one first aperture, a second grip member having at least one second aperture, and at least one U-shaped resilient portion connecting the first and second grip members.

Classes IPC  ?

  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/375 - Aménagements structurels, p. ex. boîtiers

74.

Modified high frequency neuromodulation signals, and associated systems and methods

      
Numéro d'application 17824737
Numéro de brevet 12558547
Statut Délivré - en vigueur
Date de dépôt 2022-05-25
Date de la première publication 2022-12-01
Date d'octroi 2026-02-24
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry

Abrégé

The present technology is directed generally to spinal cord modulation and associated systems and methods for treating pain and other patient conditions. In particular, the present technology includes modified high frequency neuromodulation signals and administration patterns.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

75.

MODIFIED HIGH FREQUENCY NEUROMODULATION SIGNALS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application US2022030933
Numéro de publication 2022/251366
Statut Délivré - en vigueur
Date de dépôt 2022-05-25
Date de publication 2022-12-01
Propriétaire NEVRO CORP. (USA)
Inventeur(s)
  • Lee, Dongchul
  • Bradley, Kerry

Abrégé

The present technology is directed generally to spinal cord modulation and associated systems and methods for treating pain and other patient conditions. In particular, the present technology includes modified high frequency neuromodulation signals and administration patterns.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/06 - Électrodes pour traitement à haute fréquence
  • A61N 1/02 - ÉlectrothérapieCircuits à cet effet Parties constitutives
  • G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices

76.

HFX IQ

      
Numéro d'application 018798417
Statut Enregistrée
Date de dépôt 2022-11-21
Date d'enregistrement 2023-05-27
Propriétaire Nevro Corp. (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Downloadable computer software application for use with a medical device for pain control to program, optimize, and adjust electrical stimulation therapy, based on input from the user; downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; recorded computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; downloadable mobile applications for use with a medical device for pain control to program, optimize, and adjust electrical stimulation therapy; computer software to optimize and adjust electrical stimulation therapy through a spinal cord stimulator; computer software to program, optimize and adjust electrical stimulation therapy provided by a spinal cord simulator. Medical device, namely, an implantable electrical stimulation device for pain control; medical device, namely, a spinal cord stimulator for pain control; medical device for use in tissue and neural tissue for modulating neurological signals; electrical neuromodulation therapy device for pain control; implantable pulse generator for use with a medical device for pain control; implantable pulse generator for use with a spinal cord stimulator for pain control; implantable pulse generator; pulse generator for use with a medical device for pain control; pulse generator for use with a spinal cord stimulator for pain control; pulse generator; medical device that provides electrical stimulation therapy to a patient by way of leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; medical device that provides electrical stimulation therapy to a patient by way of implantable leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; medical device for pain management that enables remote programming and optimization of electrical stimulation therapy via telemetry or wireless technology; medical device for pain management that enables remote programming, adjustment, and optimization of electrical stimulation therapy. Providing online non-downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy, based on input from the user; providing online non-downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; providing temporary use of online, non-downloadable software, namely, cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; platform as a service (PAAS) featuring a cloud-based patient management and support software platform for receiving, storing, tracking, managing, and analyzing patient medical information; software as a service (SAAS) featuring cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; providing temporary use of online, non-downloadable medical software for receiving, storing, tracking, managing, and analyzing patient medical information. Data services in the nature of healthcare services, namely, receiving health data generated by remote, patient-implanted pain management devices and mobile apps associated with the devices, analyzing that health data, and generating customized feedback for users of patient-implanted pain management devices; provision of pain management assistance services in the form of a patient support program provided remotely to assist in the use, programming and optimization of a pain management device.

77.

HFX IQ

      
Numéro d'application 018798420
Statut Enregistrée
Date de dépôt 2022-11-21
Date d'enregistrement 2023-05-27
Propriétaire Nevro Corp. (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Downloadable computer software application for use with a medical device for pain control to program, optimize, and adjust electrical stimulation therapy, based on input from the user; downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; recorded computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; downloadable mobile applications for use with a medical device for pain control to program, optimize, and adjust electrical stimulation therapy; computer software to optimize and adjust electrical stimulation therapy through a spinal cord stimulator; computer software to program, optimize and adjust electrical stimulation therapy provided by a spinal cord simulator. Medical device, namely, an implantable electrical stimulation device for pain control; medical device, namely, a spinal cord stimulator for pain control; medical device for use in tissue and neural tissue for modulating neurological signals; electrical neuromodulation therapy device for pain control; implantable pulse generator for use with a medical device for pain control; implantable pulse generator for use with a spinal cord stimulator for pain control; implantable pulse generator; pulse generator for use with a medical device for pain control; pulse generator for use with a spinal cord stimulator for pain control; pulse generator; medical device that provides electrical stimulation therapy to a patient by way of leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; medical device that provides electrical stimulation therapy to a patient by way of implantable leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; medical device for pain management that enables remote programming and optimization of electrical stimulation therapy via telemetry or wireless technology; medical device for pain management that enables remote programming, adjustment, and optimization of electrical stimulation therapy. Providing online non-downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy, based on input from the user; providing online non-downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; providing temporary use of online, non-downloadable software, namely, cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; platform as a service (PAAS) featuring a cloud-based patient management and support software platform for receiving, storing, tracking, managing, and analyzing patient medical information; software as a service (SAAS) featuring cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; providing temporary use of online, non-downloadable medical software for receiving, storing, tracking, managing, and analyzing patient medical information. Data services in the nature of healthcare services, namely, receiving health data generated by remote, patient-implanted pain management devices and mobile apps associated with the devices, analyzing that health data, and generating customized feedback for users of patient-implanted pain management devices; provision of pain management assistance services in the form of a patient support program provided remotely to assist in the use, programming and optimization of a pain management device.

78.

Variable amplitude signals for neurological therapy, and associated systems and methods

      
Numéro d'application 16420037
Numéro de brevet 11458317
Statut Délivré - en vigueur
Date de dépôt 2019-05-22
Date de la première publication 2022-10-04
Date d'octroi 2022-10-04
Propriétaire Nevro Corp. (USA)
Inventeur(s) Dawson, Chris

Abrégé

Variable amplitude signals for neurological therapy, and associated systems and methods are disclosed. A representative method includes activating automatic delivery of an electrical therapy signal to a patient's spinal cord region at a frequency in a frequency range between 1.5 kHz and 100 kHz, via at least one signal delivery contact carried by an implanted signal delivery device. The delivery can include repeatedly and automatically delivering the electrical therapy signal at each of multiple therapy signal amplitudes to the at least one signal delivery contact, without the therapy signal generating paresthesia in the patient. The foregoing process can be used as a screening tool to screen responders from non-responders in the context of a non-paresthesia-generating therapy, and/or can be used during long-term treatment, for example, for chronic pain.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

79.

SELECTIVE HIGH FREQUENCY SPINAL CORD MODULATION FOR INHIBITING PAIN WITH REDUCED SIDE EFFECTS, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 17835436
Statut En instance
Date de dépôt 2022-06-08
Date de la première publication 2022-09-29
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Alataris, Konstantinos
  • Walker, Andre B.
  • Parker, Jon
  • Chitre, Yougandh
  • Park, Sangsoo Wesley
  • Thacker, James R.

Abrégé

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region to address low back pain without creating unwanted sensory and/or motor side effects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
  • G01R 21/133 - Dispositions pour procéder aux mesures de la puissance ou du facteur de puissance en utilisant des techniques numériques
  • A61N 1/32 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/06 - Électrodes pour traitement à haute fréquence
  • A61N 1/378 - Alimentation en courant électrique

80.

EXTERNAL NEUROSTIMULATOR

      
Numéro d'application US2022021939
Numéro de publication 2022/204509
Statut Délivré - en vigueur
Date de dépôt 2022-03-25
Date de publication 2022-09-29
Propriétaire NEVRO CORP. (USA)
Inventeur(s)
  • Dixit, Apratim
  • Tzvetanov, Ivan
  • Karamian, Cameron
  • Lin, Ivan Wei Tai

Abrégé

An external neurostimulator includes a housing including a base housing and a top housing, a power source, a pulse generator, and a first and second series of spring-loaded pins electrically coupled to the pulse generator. The top housing includes a central portion, a first side door hingedly coupled to a first side of the central portion, and a second side door hingedly coupled to a second side of the central portion. Each of the first side door and the second side door include a channel formed thereon that is configured to directly receive a proximal end portion of an implantable lead. Each channel includes a series of longitudinally spaced-apart openings formed on the first side door and the second side door, respectively. The first and second series of spring-loaded pins extend through the series of longitudinally spaced-apart openings of the channel on the first and second side doors, respectively.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

81.

Handheld remote controller

      
Numéro d'application 29711761
Numéro de brevet D0964966
Statut Délivré - en vigueur
Date de dépôt 2019-11-01
Date de la première publication 2022-09-27
Date d'octroi 2022-09-27
Propriétaire Nevro Corp. (USA)
Inventeur(s) O'Leary, Jerry

82.

High frequency electromagnetic stimulation for modulating cells, including spontaneously active and quiescent cells, and associated systems and methods

      
Numéro d'application 15606869
Numéro de brevet 11446504
Statut Délivré - en vigueur
Date de dépôt 2017-05-26
Date de la première publication 2022-09-20
Date d'octroi 2022-09-20
Propriétaire Nevro Corp. (USA)
Inventeur(s) Lee, Dongchul

Abrégé

Electromagnetic stimulation for treating diseases, conditions associated with diseases and/or inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency stimulation in the range of from about 1.5 kHz to about 100 kHz may be applied to a patient's target tissue region to treat the disease, associated condition and/or to inhibit pain. Electrical stimulation in accordance with similar parameters can directly affect a cellular membrane, such as a neuron and in particular, a spontaneously active neuron and/or a quiescent neuron.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/08 - Aménagements ou circuits de surveillance, de protection, de commande ou d'indication

83.

Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods

      
Numéro d'application 17748873
Numéro de brevet 11786731
Statut Délivré - en vigueur
Date de dépôt 2022-05-19
Date de la première publication 2022-09-01
Date d'octroi 2023-10-17
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Alataris, Konstantinos
  • Walker, Andre B.
  • Parker, Jon
  • Chitre, Yougandh
  • Park, Sangsoo Wesley
  • Thacker, James R.

Abrégé

Selective high-frequency spinal chord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal chord region to address low back pain without creating unwanted sensory and/or motor side affects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Classes IPC  ?

  • A61N 1/18 - Application de courants électriques par électrodes de contact
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
  • G01R 21/133 - Dispositions pour procéder aux mesures de la puissance ou du facteur de puissance en utilisant des techniques numériques
  • A61N 1/32 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/06 - Électrodes pour traitement à haute fréquence
  • A61N 1/378 - Alimentation en courant électrique

84.

Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection

      
Numéro d'application 17468441
Numéro de brevet 11931577
Statut Délivré - en vigueur
Date de dépôt 2021-09-07
Date de la première publication 2022-07-28
Date d'octroi 2024-03-19
Propriétaire NEVRO CORP. (USA)
Inventeur(s) Parker, Jon

Abrégé

Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection are disclosed. A particular embodiment includes receiving a first input corresponding to a location of a signal delivery device implanted in a patient, establishing a positional relationship between the signal delivery device and an anatomical feature of the patient, receiving a second input corresponding to a medical indication of the patient, and, based at least in part on the positional relationship and the indication, automatically identifying a signal delivery parameter in accordance with which a pulsed electrical signal is delivered to the patient via the signal delivery device.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs

85.

HIGH FREQUENCY STIMULATION FOR TREATING SENSORY AND/OR MOTOR DEFICITS IN PATIENTS WITH SPINAL CORD INJURIES AND/OR PERIPHERAL POLYNEUROPATHY, AND ASSOCIATED SYSTEMS AND METHODS

      
Numéro d'application 17672447
Statut En instance
Date de dépôt 2022-02-15
Date de la première publication 2022-06-02
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Subbaroyan, Jeyakumar
  • Bradley, Kerry
  • Lee, Dongchul

Abrégé

High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction and/or motor dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 1.5 kHz to 100 kHz.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

86.

HFX IQ

      
Numéro de série 97433032
Statut En instance
Date de dépôt 2022-05-27
Propriétaire Nevro Corp. (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux

Produits et services

Downloadable computer software application for use with a medical device for pain control to program, optimize, and adjust electrical stimulation therapy, based on input from the user; downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; recorded computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; downloadable mobile applications for use with a medical device for pain control to program, optimize, and adjust electrical stimulation therapy Medical device, namely, an implantable electrical stimulation device for pain control; medical device, namely, a spinal cord stimulator for pain control; medical device for use in tissue and neural tissue for modulating neurological signals; electrical neuromodulation therapy device for pain control; implantable pulse generator for use with a medical device for pain control; implantable pulse generator for use with a spinal cord stimulator for pain control; implantable pulse generator and embedded computer software to optimize and adjust electrical stimulation therapy provided by a spinal cord stimulator; pulse generator for use with a medical device for pain control; pulse generator for use with a spinal cord stimulator for pain control; pulse generator and embedded computer software to program, optimize and adjust electrical stimulation therapy provided by a spinal cord stimulator; feature of a medical device that provides electrical stimulation therapy to a patient by way of leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; feature of a medical device that provides electrical stimulation therapy to a patient by way of implantable leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; feature of a medical device for pain management that enables remote programming and optimization of electrical stimulation therapy via telemetry or wireless technology; medical device for pain management that enables remote programming, adjustment, and optimization of electrical stimulation therapy

87.

HFX IQ

      
Numéro de série 97428849
Statut Enregistrée
Date de dépôt 2022-05-25
Date d'enregistrement 2026-02-10
Propriétaire Nevro Corp. ()
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux

Produits et services

Downloadable computer software application for use with a medical device for pain control to program, optimize, and adjust electrical stimulation therapy, based on input from the user; downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; recorded computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; downloadable mobile applications for use with a medical device for pain control to program, optimize, and adjust electrical stimulation therapy Medical device, namely, an implantable electrical stimulation device for pain control; medical device, namely, a spinal cord stimulator for pain control; medical device for use in tissue and neural tissue for modulating neurological signals; electrical neuromodulation therapy device for pain control; implantable pulse generator for use with a medical device for pain control; implantable pulse generator for use with a spinal cord stimulator for pain control; implantable pulse generator and embedded computer software to optimize and adjust electrical stimulation therapy provided by a spinal cord stimulator; pulse generator for use with a medical device for pain control; pulse generator for use with a spinal cord stimulator for pain control; pulse generator and embedded computer software to program, optimize and adjust electrical stimulation therapy provided by a spinal cord stimulator; feature of a medical device that provides electrical stimulation therapy to a patient by way of leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; feature of a medical device that provides electrical stimulation therapy to a patient by way of implantable leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; feature of a medical device for pain management that enables remote programming and optimization of electrical stimulation therapy via telemetry or wireless technology; medical device for pain management that enables remote programming, adjustment, and optimization of electrical stimulation therapy

88.

Neuromodulation for altering autonomic functions, and associated systems and methods

      
Numéro d'application 15333763
Numéro de brevet 11318310
Statut Délivré - en vigueur
Date de dépôt 2016-10-25
Date de la première publication 2022-05-03
Date d'octroi 2022-05-03
Propriétaire Nevro Corp. (USA)
Inventeur(s) Bradley, Kerry

Abrégé

Electrical stimulation, including high frequency stimulation, for altering autonomic functions, and associated systems and methods are disclosed. A representative method includes directing an electrical signal to a target tissue at (a) a ventral region of the patient's spinal canal, (b) a sympathetic chain structure, or (c) both (a) and (b), at a frequency in a range from 1 kHz to 100 kHz, and an amplitude that does not generate an objectionable, patient-detectable sensation.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

89.

Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods

      
Numéro d'application 17552005
Numéro de brevet 11759638
Statut Délivré - en vigueur
Date de dépôt 2021-12-15
Date de la première publication 2022-04-07
Date d'octroi 2023-09-19
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Alataris, Konstantinos
  • Walker, Andre B.
  • Parker, Jon

Abrégé

Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods are disclosed. A representative method in accordance with an embodiment of the disclosure includes creating a therapeutic effect and a sensation in a patient by delivering to the patient first pulses having a first set of first signal delivery parameters and second pulses having a second set of second signal delivery parameters, wherein a first value of at least one first parameter of the first set is different than a second value of a corresponding second parameter of the second set, and wherein the first pulses, the second pulses or both the first and second pulses are delivered to the patient's spinal cord.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/06 - Électrodes pour traitement à haute fréquence

90.

Charger controller

      
Numéro d'application 29711764
Numéro de brevet D0947765
Statut Délivré - en vigueur
Date de dépôt 2019-11-01
Date de la première publication 2022-04-05
Date d'octroi 2022-04-05
Propriétaire Nevro Corp. (USA)
Inventeur(s) O'Leary, Jerry

91.

2.4 GHz radio antenna for implanted medical devices, and associated systems and methods

      
Numéro d'application 17474023
Numéro de brevet 11684786
Statut Délivré - en vigueur
Date de dépôt 2021-09-13
Date de la première publication 2022-02-24
Date d'octroi 2023-06-27
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Sandhu, Prabdeep
  • Foreman, Bret

Abrégé

The disclosed technology provides systems and methods of communication between implanted medical devices, e.g., implanted pulse generators, and handheld consumer devices, e.g., smartphones, via standard wireless communication protocols, e.g., Bluetooth or Bluetooth Low Energy (BLE) operating in the unlicensed 2.4 GHz frequency band.

Classes IPC  ?

  • H01Q 1/27 - Adaptation pour l'utilisation dans ou sur les corps mobiles
  • H01Q 1/22 - SupportsMoyens de montage par association structurale avec d'autres équipements ou objets
  • H01Q 1/24 - SupportsMoyens de montage par association structurale avec d'autres équipements ou objets avec appareil récepteur
  • H01Q 3/00 - Dispositifs pour changer ou faire varier l'orientation ou la forme du diagramme de directivité des ondes rayonnées par une antenne ou un système d'antenne
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
  • A61N 1/378 - Alimentation en courant électrique

92.

Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods

      
Numéro d'application 16406982
Numéro de brevet 11247057
Statut Délivré - en vigueur
Date de dépôt 2019-05-08
Date de la première publication 2022-02-15
Date d'octroi 2022-02-15
Propriétaire Nevro Corp. (USA)
Inventeur(s) Gliner, Bradford Evan

Abrégé

Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods. A method for treating a patient in accordance with a particular embodiment includes selecting a neural modulation site to include a neural population of the patient's spinal cord, and selecting parameters of a neural modulation signal to at least reduce an autonomic system deficit in the patient.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

93.

Systems and methods for automatically programming patient therapy devices

      
Numéro d'application 15887929
Numéro de brevet 11198001
Statut Délivré - en vigueur
Date de dépôt 2018-02-02
Date de la première publication 2021-12-14
Date d'octroi 2021-12-14
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Thacker, James R.
  • Parker, Jon

Abrégé

Methods for automatically programming a signal generator in a patient therapy system and associated systems are disclosed. A representative method comprises retrieving data including therapy program parameters, level of efficacy, and medication use corresponding to a plurality of time periods; identifying from the data a target time period having a corresponding level of efficacy; determining from the data if medication was used during the target time period; determining from the data if medication was used during a prior time period immediately before the target time period; calculating a lead position confidence factor; and programming the signal generator to repeat therapy with the therapy program parameters corresponding to the target time period if the confidence factor is greater than a threshold value and medication was used during the prior time period and not during the target time period.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

94.

Paddle leads and delivery tools, and associated systems and methods

      
Numéro d'application 17233139
Numéro de brevet 11759631
Statut Délivré - en vigueur
Date de dépôt 2021-04-16
Date de la première publication 2021-11-04
Date d'octroi 2023-09-19
Propriétaire Nevro Corp. (USA)
Inventeur(s)
  • Wong, Mark Steven
  • Johnson, Dane

Abrégé

Paddle leads and delivery tools, and associated systems and methods are disclosed. A representative system is for use with a signal delivery paddle that is elongated along a longitudinal axis, and has a paddle length and a first cross-sectional area distribution that includes a first maxima. The system comprises a delivery tool including a proximal handle and a distal connection portion positioned to removably couple to the signal delivery paddle. The paddle and the delivery tool together have a combined second cross-sectional area distribution along the length of the paddle, with a second maxima that is no greater than the first maxima.

Classes IPC  ?

  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/04 - Électrodes
  • A61N 1/06 - Électrodes pour traitement à haute fréquence
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques

95.

RELIEF, MULTIPLIED.

      
Numéro d'application 018580468
Statut Enregistrée
Date de dépôt 2021-10-19
Date d'enregistrement 2023-03-24
Propriétaire Nevro Corp. (USA)
Classes de Nice  ?
  • 35 - Publicité; Affaires commerciales
  • 36 - Services financiers, assurances et affaires immobilières
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Medical records claims coding assistance services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from private insurance and government healthcare payers. Administration of insurance plan services featuring in the framework of physician's assistance programs that facilitate patient access to medical devices by providing physicians and other healthcare providers with insurance referral and reimbursement assistance and support services, namely, prior authorizations, prior authorization appeals, claim appeals, billing, coding, and coverage identification and guidance, patient insurance benefit investigations, and updatin g and reporting of insurance benefits to patients. Providing temporary use of online, non-downloadable software, namely, cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; Platform as a service (PAAS) featuring a cloud-based patient management and support software platform for receiving, storing, tracking, managing, and analyzing patient medical information; Software as a service (SAAS) featuring cloudbased patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; Providing temporary use of online, non-downloadable medical software for receiving, storing, tracking, managing, and analyzing patient medical information.

96.

HFX COACH

      
Numéro d'application 214075700
Statut Enregistrée
Date de dépôt 2021-10-18
Date d'enregistrement 2025-04-02
Propriétaire Nevro Corp. (USA)
Classes de Nice  ? 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Patient support program, namely, providing information, training, and guidance on use and optimization of a pain management device.

97.

HFX Cloud

      
Numéro d'application 018579582
Statut Enregistrée
Date de dépôt 2021-10-18
Date d'enregistrement 2022-02-18
Propriétaire Nevro Corp. (USA)
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Providing temporary use of online, non-downloadable software, namely, cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; platform as a service (PAAS) featuring a cloud-based patient management and support software platform for receiving, storing, tracking, managing, and analyzing patient medical information; software as a service (SAAS) featuring cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; providing temporary use of online, non-downloadable medical software for receiving, storing, tracking, managing, and analyzing patient medical information.

98.

HFX

      
Numéro d'application 018579876
Statut Enregistrée
Date de dépôt 2021-10-18
Date d'enregistrement 2022-07-15
Propriétaire Nevro Corp. (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 35 - Publicité; Affaires commerciales
  • 36 - Services financiers, assurances et affaires immobilières
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Computer software application for use with a medical device for pain control to select, optimize, and adjust electrical stimulation therapy, based on input from the user; downloadable mobile applications for use with a medical device for pain control to select, optimize, and adjust electrical stimulation therapy; computer software for use with a medical device, namely, a spinal cord stimulator for delivering pain therapy and for managing pain. Medical device, namely, an implantable electrical stimulation device for pain control; medical device, namely, a spinal cord stimulator for pain control; medical and surgical instruments and apparatus, namely, devices for use in tissue and neural tissue for modulating neurological signals and components specially adapted for use therewith; medical electrodes, electrode arrays, remote controls, chargers, and other parts and accessories specially adapted for use with an electrical stimulation device for pain control; medical device for use in tissue and neural tissue for modulating neurological signals, and parts and accessories specially adapted for use therewith, including medical electrodes, remote controls, and chargers; electrical neuromodulation therapy device for pain control, and parts and accessories specially adapted for use therewith, including medical electrodes, remote controls, and chargers; medical electrodes, electrode arrays, leads, surgical leads, paddles, paddle leads, remote controls, and chargers for medical devices, namely, implantable electrical stimulation devices and electrical stimulation devices for pain control; implantable pulse generator for use with a medical device for pain control; implantable pulse generator for use with a spinal cord stimulator for pain control; implantable pulse generator for use with a medical device, namely, a spinal cord stimulator for delivering pain therapy and for managing pain; pulse generator for use with a medical device for pain control; pulse generator for use with a spinal cord stimulator for pain control; pulse generator for use with a medical device, namely, a spinal cord stimulator for delivering pain therapy and for managing pain; medical device that provides electrical stimulation therapy to a patient by way of leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; medical device that provides electrical stimulation therapy to a patient by way of implantable leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; medical device for pain management that enables remote optimization of electrical stimulation therapy. Medical records claims coding assistance services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from private insurance and government healthcare payers. Administration of insurance plan services physician’s assistance programs in relation to physicians’ assistance programs that facilitate patient access to medical devices for providing physicians and other healthcare providers with insurance referral and reimbursement assistance and support services, namely, prior authorizations, prior authorization appeals, claim appeals, billing, coding, and coverage identification and guidance, patient insurance benefit investigations, and updating and reporting of insurance benefits to patients. patient support program, namely, providing information, training and guidance on use and optimization of a pain management device. Providing temporary use of online, non-downloadable software, namely, cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; platform as a service (PAAS) featuring a cloud-based patient management and support software platform for receiving, storing, tracking, managing, and analyzing patient medical information; software as a service (SAAS) featuring cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; providing temporary use of online, non-downloadable medical software for receiving, storing, tracking, managing, and analyzing patient medical information; providing an online, non-downloadable computer software application for use with a medical device for pain control to select, optimize, and adjust electrical stimulation therapy, based on input from the user. Providing online information in the field of pain management; remote patient support program, being remotely provided therapy services, for optimizing pain relief via use, and optimization of a pain management device; medical services, namely, electrical stimulation therapy for pain management; electrical stimulation therapy for pain management.

99.

HFX CLOUD

      
Numéro d'application 214075000
Statut Enregistrée
Date de dépôt 2021-10-18
Date d'enregistrement 2025-04-02
Propriétaire Nevro Corp. (USA)
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Providing temporary use of online, non-downloadable software, namely, cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; platform as a service (PAAS) featuring a cloud-based patient management and support software platform for receiving, storing, tracking, managing, and analyzing patient medical information; software as a service (SAAS) featuring cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; providing temporary use of online, non-downloadable medical software for receiving, storing, tracking, managing, and analyzing patient medical information.

100.

HFX Access

      
Numéro d'application 018579573
Statut Enregistrée
Date de dépôt 2021-10-18
Date d'enregistrement 2022-04-22
Propriétaire Nevro Corp. (USA)
Classes de Nice  ?
  • 35 - Publicité; Affaires commerciales
  • 36 - Services financiers, assurances et affaires immobilières

Produits et services

Medical records claims coding assistance services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from private insurance and government healthcare payers. Administration of insurance plan services in the framework of physicians assistance programmes that facilitate patient access to medical devices by providing physicians and other healthcare providers with insurance referral and reimbursement assistance and support services, namely prior authorisations, prior authorisation appeals, claim appeals, billing, coding and coverage identification and guidance, patient insurance benefit investigations, and updating and reporting of insurance benefits to patients.
  1     2     3        Prochaine page